

Jushi Holdings Inc. (JUSH) Q3 2026 Earnings Call Transcript

Revenue Increased 7% Year-over-Year to $70.5 Million, With Growth Across Wholesale and Retail Channels

Jushi (OTCMKTS:JUSHF - Get Free Report) and ICU Medical (NASDAQ: ICUI - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, valuation and dividends. Risk and Volatility Jushi has a beta of -0.63,

Elutia (NASDAQ: ELUT - Get Free Report) and Jushi (OTCMKTS:JUSHF - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk. Analyst Recommendations This is a breakdown of current ratings

BOCA RATON, Fla., July 31, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSH ), a vertically integrated, multi-state cannabis operator, today announced the completion of its previously announced continuance from the Province of British Columbia, Canada, to the State of Nevada in the United States.

BOCA RATON, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) ( CSE: JUSH ) ( OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, announces that, further to its News Releases of April 24, 2026 and June 24, 2026, it is proceeding to complete its previously announced plan of arrangement (the “Arrangement”) to be effected under the Business Corporations Act (British Columbia) (the “BCBCA”), which involves, among other things, the continuance of the Company out from the province of British Columbia, Canada and the concurrent domestication of the Company in the State of Nevada in the United States (“Continuance”).

Jushi Holdings Inc. (JUSHF) Q2 2026 Earnings Call Transcript

Jushi Holdings Inc. (JUSHF) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.06 per share a year ago.